Recordati
Stock
Stock
ISIN: IT0003828271
Ticker: REC
IT0003828271
REC
Price
Price
CHART BY
Historical dividends and forecast
Recordati has so far distributed $1.315 in 2024. The next dividend will be paid on 22.05.2025
$0.655
CHART BY
Frequently asked questions
What is Recordati's market capitalization?
The market capitalization of Recordati is $10.84B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is Recordati's Price-to-Earnings (P/E) ratio?
The Price-to-Earnings (P/E) ratio (TTM) for Recordati is 24.55. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
What is the Earnings Per Share (EPS) for Recordati?
Recordati's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $2.143. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Recordati's stock?
Currently, 11 analysts cover Recordati's stock, with a consensus target price of $58.65. Analyst ratings provide insights into the stock's expected performance.
What is Recordati's revenue over the trailing twelve months?
Over the trailing twelve months, Recordati reported a revenue of $2.37B.
What is the EBITDA for Recordati?
Recordati's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $828.12M. EBITDA measures the company's overall financial performance.
What is the free cash flow of Recordati?
Recordati has a free cash flow of $518.86M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Recordati have, and what sector and industry does it belong to?
Recordati employs approximately 4,455 people. It operates in the Health Care sector, specifically within the Pharmaceuticals: Major industry.
What is the free float of Recordati's shares?
The free float of Recordati is 96.54M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $10.84B
- EPS (TTM)
- $2.143
- Free Float
- 96.54M
- P/E ratio (TTM)
- 24.55
- Revenue (TTM)
- $2.37B
- EBITDA (TTM)
- $828.12M
- Free Cashflow (TTM)
- $518.86M
Pricing
- 1D span
- $51.08$52.95
- 52W span
- $50.72$59.78
Analyst Ratings
The price target is $58.65 and the stock is covered by 11 analysts.
Buy
5
Hold
5
Sell
1
Information
Recordati SpA engages in the research, development, manufacture, and marketing of pharmaceuticals. It operates through the Specialty and Primary Care, and Rare Diseases segments. The Specialty and Primary Care segment includes pharmaceutical chemical operations. The company was founded by Giovanni Recordati in 1926 and is headquartered in Milan, Italy.
- Employees
- 4,455
- Industries
- Pharmaceuticals: Major
- Sector
- Health Care
Identifier
- ISIN
- IT0003828271
- Primary Ticker
- REC